FierceBiotech Rating of 2011's FDA Approvals

As we've already discussed, I am a huge sucker for top anything lists and it appears FierceBiotech is too.  In this list, Fierce looks back to 2011 and rates last year's FDA approvals. 

There were some interesting ones last year, especially if you ever find yourself stung by a scorpion, suffering from the very unpleasant Clostridium difficile-associated diarrhea, restlessly dealing with restless leg syndrome, crawling with head lice or if you like to treat your heart and pulmonary system to several cheeseburgers a week.

On a more serious note, number one on their list is a new cancer drug Adcetris, which is produced by Seattle Genetics.  Adcetris is the first therapy of its kind approved since 1977 to treat Hodgkin’s lymphoma and is the first ever to be approved for the treatment of anaplastic large cell lymphoma. Hopefully, this drug will provide hope to those suffering from these types of cancer.

Please read the complete 2011 list here, and I'm excited to see what approvals the FDA has in store for us in 2012.

-The Harbor Consulting Team